Day: October 13, 2025

Wuxi, China, Oct. 13, 2025 (GLOBE NEWSWIRE) — HUHUTECH International Group Inc. (Nasdaq: HUHU) (the “Company” or “HUHUTECH”), a professional provider of factory facility management and monitoring systems, today announced its participation in the 2nd Kyushu Semiconductor Expo (the “Kyushu Expo”) in Fukuoka, Japan, held from October 8 to 9, 2025. The Kyushu Expo is the largest semiconductor-industry specialized exhibition in the Kyushu region, bringing together global and domestic leaders across the semiconductor supply chain. HUHUTECH’s participation reflects its strategic commitment to expanding visibility and engagement within Japan’s growing semiconductor sector. At the Kyushu Expo, HUHUTECH showcased its factory management control systems (FMCS), gas monitoring systems (GMS), and “HOOK UP” services, demonstrating how these solutions...

Five-year facility services agreement establishes stable cash flow and strengthens ECGI’s foundation for scalable growth IRVINE, Calif., Oct. 13, 2025 (GLOBE NEWSWIRE) — via IBN — ECGI Holdings, Inc. (OTC: ECGI) today announced it has entered into a multi-million-dollar, five-year contract to provide facility services at a commercial property in Los Angeles. The long-term agreement marks a key milestone in ECGI’s evolution from restructuring to recurring revenue generation, establishing a stable income stream that strengthens the company’s balance sheet and supports the company’s next phase of scalable, technology-integrated growth. This agreement marks the first in a series of initiatives ECGI plans to unveil this quarter, reflecting the company’s continued momentum toward sustainable growth,...

In collaboration with House of Doge and its strategic partners 21Shares and Robinhood, CleanCore will gain access to alpha-generating yield strategies designed to enhance treasury performance and long-term asset growth.House of Doge aims to accelerate Dogecoin’s adoption and real-world utility across commerce and payments House of Doge starts real-world tokenization initiatives, further accelerating the demand for dogecoin        OMAHA, Neb., Oct. 13, 2025 (GLOBE NEWSWIRE) — CleanCore Solutions, Inc. (NYSE American: ZONE) (“CleanCore” or the “Company”), today congratulated its strategic partner, House of Doge, the authorized Commercial Arm of the Dogecoin Foundation on its recently announced go-public transaction by way of a merger with Brag House Holdings Inc. (NASDAQ: TBH). The milestone represents a defining moment in...

LEIDEN, Netherlands & CAMBRIDGE, Mass., Oct. 13, 2025 (GLOBE NEWSWIRE) — ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies based on its proprietary ADAR-mediated Axiomer™ RNA editing technology platform, today announced that company management will participate in the following upcoming investor conferences: H.C. Wainwright Genetic Medicines Virtual Conference – October 14-15, 2025Presentation available on demand beginning October 14 at 7:00 am ET and virtual 1x1s on October 15 H.C. Wainwright Liver Disease Virtual Conference – October 21-22, 2025Presentation available on demand beginning October 21 at 7:00 am ET and virtual 1x1s on October 22 Chardan’s 9th Annual Genetic Medicines Conference – October 21, 2025Company management will participate...

HOUSTON, Oct. 13, 2025 (GLOBE NEWSWIRE) — Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX) (Salarius or the Company) announces that on October 10, 2025 the Company received notice from the Nasdaq Stock Market LLC (Nasdaq) that it has regained compliance with Nasdaq Listing Rule 5550(b)(1), the Equity Standard Requirement. This follows the Company’s announcement on September 9, 2025 that it had regained compliance with Nasdaq Listing Rule 5550(a)(2), the Minimum Bid Price Requirement. “Salarius is now fully compliant with all Nasdaq listing requirements, marking another critical step in our planned merger with Decoy Therapeutics,” said Mark J. Rosenblum, acting CEO and CFO of Salarius. On January 13, 2025, Salarius announced it had entered into a definitive merger agreement for a business combination with Decoy Therapeutics, Inc. (Decoy),...

PALI-2108 is the first and only PDE4 inhibitor designed to target terminal ileum and colon for fibrostenotic Crohn’s disease (FSCD) and ulcerative colitis (UC) to address significant unmet medical needs Carlsbad, CA, Oct. 13, 2025 (GLOBE NEWSWIRE) — Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade,” “Palisade Bio,” or the “Company”), a clinical-stage biopharmaceutical company developing precision therapies for autoimmune, inflammatory, and fibrotic diseases, today announced that the Canadian Intellectual Property Office (CIPO) has granted patent number 3,174,137 titled, “Gut Microbiota Bioactivated PDE4 Inhibitor Precursors.” The patent covers the composition of PALI-2108, the Company’s orally administered, first-in-class, ileocolonic-targeted PDE4 B/D inhibitor in development for the treatment of FSCD and UC. J.D. Finley, Chief Executive...

Conference call scheduled for 4:30 p.m. Eastern Time WALTHAM, Mass., Oct. 13, 2025 (GLOBE NEWSWIRE) — Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced it will hold a conference call on Thursday, October 30, 2025, at 4:30 p.m. Eastern Time to discuss financial results and provide a business update from the third quarter of 2025. To participate in the conference call, please dial (877) 346-6112 (domestic) or (848) 280-6350 (international) and ask to be joined into the Ardelyx call. Live audio of the conference call will be simultaneously webcast and will be available under the Investors section of the company’s website at www.ardelyx.com. The webcast will be archived...

Newly Appointed Interim President & CEO Stephen Jones to Provide Strategic Business Update with Recently Strengthened Capital Position DURHAM, N.C., Oct. 13, 2025 (GLOBE NEWSWIRE) — 374Water Inc. (NASDAQ: SCWO) (“374Water” or the “Company”), a global leader in organic waste destruction technology and services for the municipal, federal, and industrial markets, will hold a conference call on Wednesday, November 12, 2025 at 4:30 p.m. Eastern time to discuss its results for the third quarter ended September 30, 2025, recent executive management change and strengthened balance sheet. A press release detailing the financial results will be issued prior to the call. 374Water Interim President and CEO Stephen Jones and CFO Russell Kline will host the conference call, followed by a question-and-answer period. The conference call will...

Marking major milestone completing over two years of efforts in federal permitting process for this critical mineral mine and refinery Reno, Nev., Oct. 13, 2025 (GLOBE NEWSWIRE) —  American Battery Technology Company (NASDAQ: ABAT), an integrated critical battery materials company commercializing both its primary battery mineral manufacturing and lithium-ion battery recycling facilities, announced that it has completed all of its required baseline studies and submitted all subsequent baseline reports to the U.S. Bureau of Land Management (BLM) as part of the National Environmental Policy Act (NEPA) review process, a major milestone in the development of its Tonopah Flats Lithium Project (TFLP), one of the largest critical mineral lithium projects in the United States, one of the largest critical mineral lithium projects in the...